Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

pLV-U6-gRNA-UbC-DsRed-P2A-Bsr Citations (3)

Plasmid Article: CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.
Klann TS, Black JB, Chellappan M, Safi A, Song L, Hilton IB, Crawford GE, Reddy TE, Gersbach CA Nat Biotechnol. 2017 Apr 3. doi: 10.1038/nbt.3853.
PubMed Journal

Articles Citing pLV-U6-gRNA-UbC-DsRed-P2A-Bsr

Screening Regulatory Element Function with CRISPR/Cas9-based Epigenome Editing. Klann TS, Crawford GE, Reddy TE, Gersbach CA. Methods Mol Biol. 2018;1767:447-480. doi: 10.1007/978-1-4939-7774-1_25. PubMed
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma. Bayles I, Krajewska M, Pontius WD, Saiakhova A, Morrow JJ, Bartels C, Lu J, Faber ZJ, Fedorov Y, Hong ES, Karnuta JM, Rubin B, Adams DJ, George RE, Scacheri PC. J Clin Invest. 2019 Oct 1;129(10):4377-4392. doi: 10.1172/JCI127718. PubMed
Synergistic CRISPRa-Regulated Chondrogenic Extracellular Matrix Deposition Without Exogenous Growth Factors. Farhang N, Davis B, Weston J, Ginley-Hidinger M, Gertz J, Bowles RD. Tissue Eng Part A. 2020 Nov;26(21-22):1169-1179. doi: 10.1089/ten.TEA.2020.0062. Epub 2020 Jul 9. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.